Cortical excitability in neuroleptic-naive first-episode schizophrenic patients (Q44777022)

6 December 2017

Cortical excitability in neuroleptic-naive first-episode schizophrenic patients (English)

1 reference

6 December 2017

0 references

4

Berthold Langguth

1 reference

6 December 2017

Peter Eichhammer

1

1 reference

6 December 2017

Rainer Wiegand

2

1 reference

6 December 2017

Alexander Kharraz

3

1 reference

6 December 2017

Harald Binder

5

1 reference

6 December 2017

Göran Hajak

6

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

6 December 2017

Schizophrenia Research

1 reference

6 December 2017

67

1 reference

6 December 2017

2-3

1 reference

6 December 2017

253-259

1 reference

Electrophysiological responses to transcranial magnetic stimulation in depression and schizophrenia

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Serotonin and Hallucinogens

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Transcallosal inhibition and motor conduction studies in patients with schizophrenia using transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Intracortical inhibition and facilitation in different representations of the human motor cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Motor responses to transcranial magnetic stimulation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Ketamine increases human motor cortex excitability to transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Chronic administration of haloperidol and olanzapine attenuates ketamine-induced brain metabolic activation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

A study of transcallosal inhibition in schizophrenia using transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

A transcranial magnetic stimulation study of inhibitory deficits in the motor cortex in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

A transcranial magnetic stimulation study of the effects of olanzapine and risperidone on motor cortical excitability in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

A transcranial magnetic stimulation study of abnormal cortical inhibition in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Altered cortical excitability in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Corticocortical inhibition in human motor cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

The assessment and analysis of handedness: The Edinburgh inventory

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Motor cortical excitability in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

An investigation of motor function in schizophrenia using transcranial magnetic stimulation of the motor cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Neurological soft signs in never-treated schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

A systems model of altered consciousness: integrating natural and drug-induced psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

The relative metabolic demand of inhibition and excitation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Developmentally moderated expressions of the neuropathology underlying schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Variation in the response to transcranial magnetic brain stimulation in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2803%2900223-8

7 January 2021

10.1016/S0920-9964(03)00223-8

Identifiers

DOI

1 reference

6 December 2017

1 reference